Ultrasound technology provider ENDRA Life Sciences Inc. announces that it has received Institutional Review Board approval from China’s Shanghai General Hospital, for the first clinical study of ENDRA’s Thermo Acoustic Enhanced UltraSound device to assess non-alcoholic fatty liver disease in that market.